BSEBrawn Biotech LtdHighNegative
Announced Mon, 5 Jan · 18:16 IST

Resignation of Ms. Pooja Pandey (CFO and KMP).

Cfo ResignedKmp ResignedManagement Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Ms. Pooja Pandey has resigned from the position of Chief Financial Officer and Key Managerial Personnel of Brawn Biotech Ltd, effective from the close of business hours on January 5, 2026. The reason cited is personal circumstances, specifically pre-occupation and unavoidable personal matters. She confirmed there are no other material reasons behind her resignation. The company has disclosed this change under SEBI Listing Regulations and attached her resignation letter as Annexure II. No replacement or new CFO appointment has been announced in this filing.

Likely market impact

The sudden exit of the CFO, without an immediate replacement announced, could create short-term uncertainty around financial reporting and compliance oversight at Brawn Biotech. Retail investors should watch for the company's next update on the appointment of a new CFO, as a prolonged vacancy at this position may be a minor governance concern for a small-cap biotech firm.